Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the cyberknife market grown in recent years?

The scale of the cyberknife market has seen a significant increase lately. The market valuation is expected to rise from $0.63 billion in 2024 to $0.73 billion in 2025, representing a compound annual growth rate (CAGR) of 16.6%. The surge noticed in the historical period is due to factors like increasing cancer rates, an aging population, a shift towards precision medicine, patients opting for non-invasive methods, and advancements in radiotherapy.

How is the cyberknife market size expected to evolve during the forecast period?

The cyberknife market is predicted to experience a swift expansion in the coming years, going up to “$1.35 billion by 2029 with a CAGR of 16.6%. Various factors contributing to this growth in the forecast period include a higher prevalence of cancer worldwide, improvements in cancer research, expanded healthcare accessibility, an increase in awareness and knowledge, and fusion with multi-disciplinary methods. Noteworthy trends in the forecast period encompass rising usage of proton therapy, transition towards standalone and outpatient centers, treatment plans focused on patients, burgeoning clinical proofs and investigation, as well as a rise in remote treatment planning and telemedicine.

Get your cyberknife market report here!

https://www.thebusinessresearchcompany.com/report/cyberknife-global-market-report

Which key drivers are propelling the cyberknife market’s growth?

The escalating prevalence of cancer is anticipated to fuel the cyberknife market’s expansion. Cancer, a serious disease characterized by the rapid and uncontrolled multiplication of body cells leading to abnormal growth, heightens the demand for Cyberknife. This FDA-approved, non-invasive, non-surgical, and painless treatment option provides an alternative to traditional radiation therapy for various types of cancer. Moreover, ongoing research and development efforts aimed at enhancing the Cyberknife system and broadening its application scope are projected to further stimulate market growth. For instance, ABC News Internet Ventures, a US-based media organization, reported in January 2022 that the expected count of newly diagnosed cancer cases for the year approximates 2 million. This depicts a major surge from the 1 million new cases declared in 2021. With an estimated daily diagnosis of around 5,250 new cancer cases (summing up to 1,918,030 Americans diagnosed with cancer), the increasing prevalence of the disease is certainly triggering a spike in the cyberknife market.

What are the market segments in the cyberknife industry?

The cyberknife market covered in this report is segmented –

1) By Type: Linear Accelerator-Based, Standalone Cyberknife

2) By Application: Tumor, Cancer, Vascular malformation, Other Applications

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Center, Radiotherapy Centers, Other End Users

Subsegments:

1) By Linear Accelerator-Based: Conventional Linear Accelerators, Advanced Linear Accelerators, Integrated Linear Accelerators

2) By Standalone Cyberknife: Fixed Cyberknife Systems, Mobile Cyberknife Systems, Upgraded Cyberknife Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10562&type=smp

Which leading companies are shaping the growth of the cyberknife market?

Major companies operating in the cyberknife market include Accuray Incorporated, Elekta AB, Medtronic plc, Varian Medical Systems Inc., Brainlab AG, Ion Beam Applications S.A., Mevion Medical Systems Inc., Zap Surgical Systems Inc., Xcision Medical Systems LLC, ViewRay Inc., Hitachi Ltd., Mitsubishi Electric Corporation, Best Theratronics Ltd., Siemens Healthineers AG, Toshiba Medical Systems Corporation, Orfit Industries NV, Technicare Medical Systems Inc., ProTom International Inc., Advanced Accelerator Applications S.A., Theragenics Corporation, IntraOp Medical Corporation, CIVCO Radiotherapy, IsoRay Medical Inc., RaySearch Laboratories AB, RefleXion Medical Inc., Shinva Medical Instrument Co. Ltd., Klarity Medical Products, MIM Software Inc., Elekta Instrument AB, Nordion Inc.

What key trends are currently impacting the cyberknife market’s development?

Key entities in the cyberknife industry are concentrating their efforts on innovating solutions like medical training programs to heighten treatment accuracy, better patient results, and broaden the span of conditions that can be treated while reducing side effects typical with conventional radiation therapies. Medical training programs are structured education plans meant to improve the capabilities and knowledge of healthcare professionals, focusing on specific medical technologies, procedures, and most effective methods to enhance patient care results. For example, in September 2024, Accuray Incorporated, a company based in the US that manufactures radiation therapy systems, initiated the CyberKnife S7 System for medical professionals at its education center. This facility serves as an all-inclusive education center aimed at improving the skills of medical experts engaged in radiosurgery and radiotherapy, providing customized training programs and hands-on exposure with the CyberKnife and Radixact system.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10562

Which geographic areas are influencing the growth of the cyberknife market?

North America was the largest region in the cyberknife market in 2024. The regions covered in the cyberknife market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Bladder Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report

Breast Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Blood Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: